DISC MEDICINE INC. - COMMON STOCK

Disc Medicine Announces Underwritten Offering of Common Stock

14 6 2024 07:03:53 提供 Nasdaq GlobeNewswire

Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress

14 6 2024 06:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine to Participate in the Jefferies Global Healthcare Conference

30 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress

14 5 2024 09:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference

13 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update

09 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)

01 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

21 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024

06 3 2024 15:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer

26 2 2024 07:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

20 2 2024 07:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera

09 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer

07 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 16:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board

20 12 2023 15:30:00 提供 Nasdaq GlobeNewswire

Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting

11 12 2023 19:30:00 提供 Nasdaq GlobeNewswire

Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting

11 12 2023 11:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin

14 11 2023 15:44:17 提供 Nasdaq GlobeNewswire

Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update

09 11 2023 07:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine to Participate in Upcoming Investor Conferences

08 11 2023 15:30:11 提供 Nasdaq GlobeNewswire